These characters make EBI2 a precisely controlled GPCR at its expression and signaling levels by IFN‐related regulators (i.e., IFN‐γ, oxysterol, STAT, IFN‐I, and ISGs) during the development of SLE. The gene discussed is IFNG; the disease is systemic lupus erythematosus.